Raymond James Financial Services Advisors’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $208K | Sell |
60,894
-4,203
| -6% | -$14.3K | ﹤0.01% | 3160 |
|
|
2024
Q2 | $304K | Buy |
65,097
+1,218
| +2% | +$5.69K | ﹤0.01% | 2858 |
|
|
2024
Q1 | $474K | Buy |
63,879
+3,709
| +6% | +$27.5K | ﹤0.01% | 2556 |
|
|
2023
Q4 | $610K | Buy |
60,170
+13,574
| +29% | +$138K | ﹤0.01% | 2277 |
|
|
2023
Q3 | $363K | Sell |
46,596
-1,169
| -2% | -$9.12K | ﹤0.01% | 2515 |
|
|
2023
Q2 | $393K | Buy |
47,765
+2,380
| +5% | +$19.6K | ﹤0.01% | 2486 |
|
|
2023
Q1 | $329K | Buy |
45,385
+5,032
| +12% | +$36.5K | ﹤0.01% | 2589 |
|
|
2022
Q4 | $358K | Buy |
40,353
+60
| +0.1% | +$532 | ﹤0.01% | 2466 |
|
|
2022
Q3 | $493K | Buy |
40,293
+3,265
| +9% | +$39.9K | ﹤0.01% | 2253 |
|
|
2022
Q2 | $438K | Buy |
37,028
+62
| +0.2% | +$733 | ﹤0.01% | 2353 |
|
|
2022
Q1 | $703K | Sell |
36,966
-3,493
| -9% | -$66.4K | ﹤0.01% | 2170 |
|
|
2021
Q4 | $1.07M | Sell |
40,459
-12,453
| -24% | -$331K | ﹤0.01% | 1941 |
|
|
2021
Q3 | $2.17M | Buy |
52,912
+4,470
| +9% | +$184K | ﹤0.01% | 1441 |
|
|
2021
Q2 | $2.74M | Buy |
48,442
+444
| +0.9% | +$25.2K | 0.01% | 1304 |
|
|
2021
Q1 | $2.02M | Sell |
47,998
-12,750
| -21% | -$536K | ﹤0.01% | 1403 |
|
|
2020
Q4 | $4.26M | Buy |
60,748
+12,623
| +26% | +$885K | 0.01% | 903 |
|
|
2020
Q3 | $1.35M | Buy |
48,125
+1,498
| +3% | +$42K | ﹤0.01% | 1369 |
|
|
2020
Q2 | $1.38M | Buy |
46,627
+17,224
| +59% | +$509K | ﹤0.01% | 1307 |
|
|
2020
Q1 | $583K | Buy |
29,403
+6,580
| +29% | +$130K | ﹤0.01% | 1450 |
|
|
2019
Q4 | $676K | Buy |
22,823
+4,602
| +25% | +$136K | ﹤0.01% | 1779 |
|
|
2019
Q3 | $414K | Sell |
18,221
-405
| -2% | -$9.2K | ﹤0.01% | 2024 |
|
|
2019
Q2 | $461K | Sell |
18,626
-4,306
| -19% | -$107K | ﹤0.01% | 1981 |
|
|
2019
Q1 | $561K | Buy |
22,932
+694
| +3% | +$17K | ﹤0.01% | 1820 |
|
|
2018
Q4 | $506K | Sell |
22,238
-6,599
| -23% | -$150K | ﹤0.01% | 1660 |
|
|
2018
Q3 | $918K | Buy |
28,837
+6,771
| +31% | +$216K | ﹤0.01% | 1518 |
|
|
2018
Q2 | $791K | Buy |
22,066
+10,556
| +92% | +$378K | ﹤0.01% | 1574 |
|
|
2018
Q1 | $382K | Buy |
11,510
+1,551
| +16% | +$51.5K | ﹤0.01% | 1890 |
|
|
2017
Q4 | $306K | Buy |
+9,959
| New | +$306K | ﹤0.01% | 2005 |
|